ArticleJAMA network open2021

Real-World Survival Outcomes Associated With First-Line Immunotherapy, Targeted Therapy, and Combination Therapy for Metastatic Clear Cell Renal Cell Carcinoma.

Nicholas H Chakiryan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.